| Q67986742 | 4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse |
| Q34573288 | A gene(s) for all-trans-retinoic acid-induced forelimb defects mapped and confirmed to murine chromosome 11 |
| Q41040034 | A novel assay for retinoic acid catabolic enzymes shows high expression in the developing hindbrain. |
| Q34164291 | Adverse effects of retinoids |
| Q52203756 | All-trans retinoic acid stimulates and maintains neurite outgrowth in nerve growth factor-supported developing chick embryonic sympathetic neurons. |
| Q52238670 | Assessment of the developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin, and 13-cis retinoic acid using FETAX. |
| Q28082113 | Building a second brain in the bowel |
| Q48233384 | CRBP I and CRABP I localisation during olfactory nerve development |
| Q40872590 | Cell death/apoptosis: normal, chemically induced, and teratogenic effect |
| Q35196271 | Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci |
| Q72591794 | Comparative teratogenic activities of two retinoids: Effects on palate and limb development |
| Q36028706 | Comparative teratogenicity of nine retinoids in the rat |
| Q41224267 | Comparative teratogenicity of three retinoids: the arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570. |
| Q36791827 | Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid |
| Q38657897 | Deleterious effects of drugs on the developing nervous system. |
| Q42591731 | Desferrioxamine, ocular toxicity, and trace metals |
| Q44799614 | Dietary vitamin A intake below the recommended daily intake during pregnancy and the risk of congenital diaphragmatic hernia in the offspring |
| Q52196596 | Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse. |
| Q36322964 | Does the cranial mesenchyme contribute to neural fold elevation during neurulation? |
| Q38729529 | Dose response and structure-activity considerations in retinoid-induced dysmorphogenesis |
| Q44028402 | Evaluation of the developmental toxicity of crocetin on Xenopus |
| Q41676501 | Expression of Notch 1, 2 and 3 is regulated by epithelial-mesenchymal interactions and retinoic acid in the developing mouse tooth and associated with determination of ameloblast cell fate |
| Q44800991 | Expression of retinoic acid receptor genes in neural crest-derived cells during mouse facial development |
| Q42244382 | Fetal hydrocephalus and ear anomalies associated with maternal use of isotretinoin |
| Q33698646 | Hemifacial microsomia and treatment options for auricular replacement: A review of the literature |
| Q64901201 | Identification and characterization of mRNAs and lncRNAs in the uterus of polytocous and monotocous Small Tail Han sheep (Ovis aries). |
| Q52252166 | Influence of retinoids and EGF on growth of embryonic mouse palatal epithelia in culture. |
| Q71790681 | Interlaboratory evaluation of embryotoxicity in the postimplantation rat embryo culture |
| Q36268973 | Intracellular actions of vitamin A. |
| Q45091772 | Large-scale reprogramming of cranial neural crest gene expression by retinoic acid exposure |
| Q50901864 | Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids. |
| Q28329446 | Malformations of the maxillofacial region induced by retinoids in an experimental system |
| Q40144296 | Megavitamins: Fact and fancy |
| Q36698081 | Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis |
| Q36214077 | Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential? |
| Q34663336 | Periconceptional vitamin A use: how much is teratogenic? |
| Q48245813 | Postnatal effects of retinoic acid on cerebellar development |
| Q38625359 | Potential human developmental toxicants and the role of animal testing in their identification and characterization |
| Q41143690 | Preconception care: a means of prevention |
| Q43263305 | Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin |
| Q37452626 | Prenatal exposure to antiepileptic drugs and dental agenesis |
| Q47660027 | Prolactin lowering activity of the retinoid Ro 14-9706 affecting lactation and pup survival |
| Q35032940 | Regulation and patterns of endogenous and exogenous gene expression during differentiation of embryonal carcinoma cells |
| Q52213986 | Regulation of TGF beta 3 gene expression in embryonic palatal tissue. |
| Q33922396 | Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor |
| Q36295422 | Reprogramming of the retinoic acid pathway in decidualizing human endometrial stromal cells |
| Q60439762 | Retinoic acid and development of the retina |
| Q34018035 | Retinoic acid enhances osteogenesis in cranial suture-derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosis |
| Q54267853 | Retinoic acid receptor beta 2 mRNA is elevated by retinoic acid in vivo in susceptible regions of mid-gestation mouse embryos. |
| Q70082955 | Retinoids inhibit the differentiation of embryonic-mouse mesenchymal cells in vitro |
| Q64969520 | Sonic Hedgehog Signaling Is Required for Cyp26 Expression during Embryonic Development. |
| Q42828419 | Temporal distribution, localization and metabolism of all-trans-retinol, didehydroretinol and all-trans-retinal during Xenopus development |
| Q44008315 | Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670). |
| Q44597326 | Teratogenic effects of chronic ingestion of high levels of vitamin A in cats |
| Q44230427 | Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture |
| Q72560178 | Teratogenicity of isotretinoin |
| Q35127991 | Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established |
| Q84589610 | The Relative Semi-quantification of mRNA Expression as a Useful Toxicological Endpoint for the Identification of Embryotoxic/Teratogenic Substances |
| Q28590504 | The STRA6 receptor is essential for retinol-binding protein-induced insulin resistance but not for maintaining vitamin A homeostasis in tissues other than the eye |
| Q53019029 | The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-r |
| Q71426369 | The influence of excess vitamin A on neural tube closure in the mouse embryo |
| Q37789002 | The role of CYP26 enzymes in defining appropriate retinoic acid exposure during embryogenesis |
| Q48387685 | Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation |
| Q40328195 | Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids. |
| Q67489569 | Transgenic mice expressing a constitutively active retinoic acid receptor in the lens exhibit ocular defects |
| Q46665837 | Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice |
| Q41416446 | Tretinoin: a review of the nonclinical developmental toxicology experience |
| Q52245142 | Vitamin A acetate: a behavioral teratology study in rats. |
| Q41513760 | Vitamin A and its congeners |
| Q68010781 | Vitamin A effects on fetal mouse cephalic acetylcholinesterase and choline acetyltransferase |
| Q68657091 | Vitamin A supplementation increases levels of retinoic acid compounds in human plasma: possible implications for teratogenesis |
| Q41749847 | Vitamin A teratogenicity and risk assessment in the macaque retinoid model |
| Q57752265 | Vitamin A: A newly recognized human teratogen. Harbinger of things to come? |
| Q44095018 | Vitamin B6 therapy during childbearing years: cause for caution? |
| Q34028824 | Vitamins and bone health: beyond calcium and vitamin D. |